PEOPLE ON THE MOVE
Array BioPharma
Hospira’s finance VP has joined Array BioPharma, a small molecule oncology company.
Patricia Henahan will take over as chief financial officer, following a career at Hospira, AstraZeneca, Eli Lilly and MedImmune and experience in strategic planning, financial analysis, commercialization, R&D, operations and alliance management.
Array is awaiting results of its Nemo and Columbus Phase III trials and plans regulatory filings soon for binimetinib, an MEK inhibitor, and encorafenib, a BRAF inhibitor.
